Dudediligence.

Annexon, Inc

ANNXNASDAQ · Pharmaceutical Preparations
Write an idea

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

149.4M

on 2025-12-31, from 109.4M on 2024-12-31 10-K ↗

a raise that quarter, at its price

50M100M150MDec2024Dec2025$2.60

Newest

S-3 of 2024-08-12. Not read yet. S-3 ↗

6 of its filings are not read yet.

Warrants

The 10-Q filed 2026-08-12 is not read yet.

Cash

4.3 quarters

$209.2M on 2026-06-30 ÷ $48.3M a quarter of operating cash used, the average of four quarters. 10-Q ↗

Raised
DateWhatSharesPriceGrossFiling
2025-11-12Public offering incl. 3.75M pre-funded28,846,153$2.60$75.0M424B5 ↗

Also on file: up to $50.0M term loans agreed 2026-07-30 8-K ↗